Mid-Day Market Update: Gold Rises Over 1%; Provention Bio Shares Plunge
Midway through trading Tuesday, the Dow traded down 1.09% to 34,408.75 while the NASDAQ rose 0.01% to 14,641.07. The S&P also fell, dropping 0.60% to 4,326.41.
42 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47.
BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday.
Mid-Morning Market Update: Markets Mostly Lower; ISM Services PMI Falls In June
Following the market opening Tuesday, the Dow traded down 0.62% to 34,569.49 while the NASDAQ rose 0.19% to 14,667.72. The S&P also fell, dropping 0.27% to 4,340.67.
Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving Today
Odonate Therapeutics, Inc. (NASDAQ: ODT), Opthea Limited (NASDAQ: OPT), ALX Oncology Holdings Inc.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning, 51 companies reached new 52-week lows.
Provention Bio’s Teplizumab Application Receives CRL For Type-1 Diabetes; Stock Drops
The FDA has issued a Complete Response Letter (CRL) to Provention Bio Inc’s (NASDAQ:PRVB) teplizumab marketing application seeking approval for the delay…
Provention Bio Receives Complete Response Letter To Biologics License Application For Teplizumab
Provention Bio, Inc. (NASDAQ:PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete
The Daily Biotech Pulse: Iterum’s Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 1)